Institutional Ownership
Relmada Therapeutics Inc
CUSIP 75955J402COMRLMDQ1 2026
Institutional Holders
100
13F filers
Shares Held
80.11M
Aggregate institutional
Institutional Value
$551.65M
Q1 2026
Net New Holders
+24
33 new · 9 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions33
Increased27
Decreased24
Sold out9
Institutional Holders
100 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Janus Henderson Group PLC | 11.06M | $76.89M | +3.79M | Added |
| 2 | Squadron Capital Management LLC | 8.47M | $58.98M | +1.77M | Added |
| 3 | Spruce Street Capital LP | 6.26M | $43.00M | +2.18M | Added |
| 4 | Venrock Adviser, LLC | 4.84M | $33.71M | +4.84M | New |
| 5 | Adage Capital Partners Gp, L.L.C. | 4.76M | $33.15M | +493.2K | Added |
| 6 | Orbimed Advisors LLC | 4.72M | $32.82M | +2.11M | Added |
| 7 | Marshall Wace, LLP | 4.48M | $31.19M | +1.29M | Added |
| 8 | Millennium Management LLC | 3.91M | $27.19M | +2.23M | Added |
| 9 | Ra Capital Management, L.P. | 2.95M | $20.51M | +2.95M | New |
| 10 | Ikarian Capital, LLC | 2.69M | $18.71M | −380.0K | Reduced |
90 more institutional holders on Premium
See every fund holding Relmada Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders